MyFinsight
Home
About
Contact
crnx: the income statement
Download
Download image
Unrealized gain on
investment securities
$594K
(-73.34%↓ Y/Y)
Comprehensive loss
-$129,518K
(-73.62%↓ Y/Y)
Total other
comprehensive income
$573K
Unrealized loss on foreign
currency
-$21K
Net loss
-$130,091K
(-69.33%↓ Y/Y)
Interest income
$12,544K
(13.97%↑ Y/Y)
Loss before equity
method investment
-$130,091K
(-269.33%↓ Y/Y)
Total other income,
net
$12,495K
(13.91%↑ Y/Y)
Other expense, net
-$49K
(-32.43%↓ Y/Y)
Loss from operations
-$142,586K
(-62.40%↓ Y/Y)
Revenues
$143K
Total operating
expenses
$142,729K
(62.57%↑ Y/Y)
Selling, general and
administrative
$52,265K
(101.86%↑ Y/Y)
Research and development
$90,464K
(46.13%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Crinetics Pharmaceuticals, Inc. (CRNX)
Crinetics Pharmaceuticals, Inc. (CRNX)